ContractPodAi is now LeahGet a Demo

A Global Pharmaceutical Oncology Division Streamlines Contract Management with Leah Through Phased Implementation

The oncology division of a global pharmaceutical company faced the complex challenge of managing contracts within a highly regulated pharmaceutical environment while maintaining independence from the broader corporate instance. The organization required extensive validation documentation, multi-departmental security approvals, and comprehensive change management planning to ensure compliance and successful adoption.

A Global Pharmaceutical Oncology Division Streamlines Contract Management with Leah Through Phased Implementation

“In these large pharmaceutical environments, platform implementations take four to five times longer than you'd expect due to validation requirements.”

the Senior Director of Business Operations

Challenge

The oncology division of a global pharmaceutical company faced the complex challenge of managing contracts within a highly regulated pharmaceutical environment while maintaining independence from the broader corporate instance. The organization required extensive validation documentation, multi-departmental security approvals, and comprehensive change management planning to ensure compliance and successful adoption.

Implementation

Under the leadership of System Owner the Senior Director of Business Operations, the division took a methodical approach to implementing Leah CLM platform with 30 user licenses and Leah capabilities. The implementation strategy reflected careful change management planning with a phased rollout:

• Core contracting team deployment for initial two weeks

• Feedback loops and critical improvement cycles

• Expansion to project management team

• Broader business user rollout planned for 1-2 months post-launch

"We took forever to get to this point to ensure configuration solidity," explains Horn. "Change management is challenging and requires measured adoption."

The implementation team focused on establishing robust foundations:

• Comprehensive workflow configuration per application type

• Detailed user roles and permissions setup

• Customized intake form development

• Integration with existing business process documentation

• Thorough security questionnaire completion across multiple departments

Outcome

While still in the final UAT phase targeting September go-live, early indicators show promise:

• Configuration quality described as "pretty solid" after extensive preparation

• UAT approximately halfway complete with no major issues reported

• Strong user interest in upcoming features, particularly version tracking and redline stacking capabilities

• Clear governance structures established for issue management and enhancement requests

1. Methodical Validation Process

• Extensive documentation meeting pharmaceutical requirements

• Multi-departmental security review coordination

• Comprehensive UAT execution

2. Strong Change Management

• Phased rollout strategy

• Regular feedback incorporation

• Clear communication channels

3. Vendor Partnership

• Daily UAT collaboration

• Responsive support for urgent needs

• Proactive feature demonstrations

The Oncology division's implementation experience and requirements will help inform future enterprise-wide deployment decisions. The team's thorough approach to validation and change management provides valuable insights for other regulated industry implementations.

"We're developing strong requirements that can inform the larger organizational project," notes Horn. "The key is maintaining measured progress while meeting all compliance requirements."

---

This case study captures implementation best practices and early indicators. Follow-up studies will document quantified business outcomes post-production deployment.

Ready to transform your legal operations?

See What Leah Can Do